FDA advisors suggest Eli Lilly's Alzheimer's drug donanemab, paving method for approval
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, Would possibly 3, 2023. Eli Lilly & Co.’s stocks climbed in early US buying and selling after its experimental drug for Alzheimer’s slowed